Skip to main content
27/11/2023 - 15:25

Botanix taps investors for $13.5m

27/11/2023 - 15:25

Bookmark

Save articles for future reference.

Clinical dermatology company Botanix Pharmaceuticals is tapping investors for $13.5 million to help fund the commercial launch of its lead treatment.

X

To read our articles you will need to either login or subscribe.